-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cytek Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q2 2024.
- Cytek Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.34M, a 47% decline year-over-year.
- Cytek Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $9.56M, a 6% decline year-over-year.
- Cytek Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $12.1M, a 296% increase from 2022.
- Cytek Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $3.06M.
- Cytek Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$3.22M, a 518% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)